Hyperandrogenism increases late spontaneous miscarriage in polycystic ovary syndrome women due to cervical insufficiency? A propensity-score matching study
- PMID: 40022012
- PMCID: PMC11869477
- DOI: 10.1186/s12884-025-07342-4
Hyperandrogenism increases late spontaneous miscarriage in polycystic ovary syndrome women due to cervical insufficiency? A propensity-score matching study
Abstract
Background: The potential effects of hyperandrogenism (HA) on pregnancy outcomes among polycystic ovary syndrome (PCOS) patients are still unknown. The aim of this study was to explore the impact of HA on miscarriage rate after in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) treatment in PCOS patients.
Methods: Women diagnosed with PCOS who underwent the first autologous IVF/ICSI cycles using gonadotropin-releasing hormone agonist (GnRH-a) protocols for ovarian stimulation during the period from January 2016 to December 2022 were included. Women were divided into the HA and non-HA group according to Hyperandrogenemia (serum testosterone level > 0.48 ng/mL), and/or the presence of hirsutism. Pregnancy outcomes were compared before and after propensity-score matching (PSM). Multiple logistic regression models were performed to demonstrate the independent impact of HA on pregnancy outcomes.
Results: A total of 3066 patients were included. PCOS women with HA experienced a notably higher rates of late spontaneous miscarriage (LSM) as compared to those without HA before and after PSM (8.8% versus 3.5%, P < 0.001; 8.9% versus 3.9%, P = 0.001, respectively), but comparable rates of clinical pregnancy, early spontaneous miscarriage, and live birth. After adjusting for possible confounding factors, the logistic regression confirmed that HA was independently associated with the increased risk of LSM (adjusted OR: 2.540, 95% confidence interval: 1.326-4.672, P = 0.003). For the specific reasons for LSM, cervical insufficiency accounted for a larger proportion in women with HA than their counterparts without HA (15/32 versus 7/33, P = 0.029).
Conclusions: Androgen excess is postulated to play a role in late miscarriage via increased likelihood of cervical insufficiency.
Trial registration: N/A.
Keywords: Cervical insufficiency; Hyperandrogenism; Late spontaneous miscarriage; Polycystic ovarian syndrome; Propensity score matching.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study adhered to the Declaration of Helsinki regarding medical protocol and ethics, and the Ethics Review Committee of the First Hospital of Zhengzhou University approved the study(2023-KY-1049-002). Written informed consent was waived due to the retrospective nature of the study, in accordance with the national legislation and institutional requirements. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures


Similar articles
-
[Effect of hyperandrogenism on pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer].Zhonghua Yi Xue Za Zhi. 2023 Apr 11;103(14):1042-1048. doi: 10.3760/cma.j.cn112137-20220926-02032. Zhonghua Yi Xue Za Zhi. 2023. PMID: 37032154 Chinese.
-
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD006105. doi: 10.1002/14651858.CD006105.pub4. Cochrane Database Syst Rev. 2020. PMID: 33347618 Free PMC article.
-
Association between hyperandrogenism and adverse pregnancy outcomes in patients with different polycystic ovary syndrome phenotypes undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis.Gynecol Endocrinol. 2021 Aug;37(8):694-701. doi: 10.1080/09513590.2021.1897096. Epub 2021 Mar 11. Gynecol Endocrinol. 2021. PMID: 33703999
-
Body mass index and basal androstenedione are independent risk factors for miscarriage in polycystic ovary syndrome.Reprod Biol Endocrinol. 2018 Nov 19;16(1):119. doi: 10.1186/s12958-018-0438-7. Reprod Biol Endocrinol. 2018. PMID: 30454060 Free PMC article.
-
Reproductive outcomes of dual trigger with combination GnRH agonist and hCG versus trigger with hCG alone in women undergoing IVF/ICSI cycles: a retrospective cohort study with propensity score matching.BMC Pregnancy Childbirth. 2022 Jul 22;22(1):583. doi: 10.1186/s12884-022-04899-2. BMC Pregnancy Childbirth. 2022. PMID: 35869444 Free PMC article.
Cited by
-
Predictive value of serum sortilin, HMGB1, and galanin-like peptide for gestational diabetes mellitus in women with polycystic ovary syndrome.Front Endocrinol (Lausanne). 2025 May 19;16:1602622. doi: 10.3389/fendo.2025.1602622. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40458174 Free PMC article.
References
-
- Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–55. - PubMed
-
- Yu Z, Li Y, Zhao S, Liu F, Zhao H, Chen ZJ. Evidence of positive selection of genetic variants associated with PCOS. Hum Reprod. 2023;38(Supplement2):ii57–68. - PubMed
-
- Pasquali R, Zanotti L, Fanelli F, Mezzullo M, Fazzini A, Morselli LA, Repaci A, Ribichini D, Gambineri A. Defining Hyperandrogenism in Women with Polycystic Ovary Syndrome: a challenging perspective. J Clin Endocr Metab. 2016;101(5):2013–22. - PubMed
-
- Palomba S, Daolio J, La Sala GB. Oocyte competence in women with polycystic ovary syndrome. Trends Endocrin Met. 2017;28(3):186–98. - PubMed
-
- Palomba S. Is fertility reduced in ovulatory women with polycystic ovary syndrome? An opinion paper. Hum Reprod. 2021;36(9):2421–8. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous